
The growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer), new research shows. Inhibition of this receptor could be a new and effective way of treating patients.
http://www.sciencedaily.com/releases/2015/09/150915090655.htm